- Home
- MAIA vs BGM Comparison
MAIA vs BGM Comparison
Compare MAIA & BGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- BGM
- Stock Information
- Founded
- MAIA 2018
- BGM 2019
- Country
- MAIA United States
- BGM China
- Employees
- MAIA N/A
- BGM N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- BGM
- Sector
- MAIA Health Care
- BGM
- Exchange
- MAIA Nasdaq
- BGM NYSE
- Market Cap
- MAIA 65.9M
- BGM 52.8M
- IPO Year
- MAIA 2022
- BGM 2021
- Fundamental
- Price
- MAIA $2.13
- BGM $6.61
- Analyst Decision
- MAIA
- BGM
- Analyst Count
- MAIA 0
- BGM 0
- Target Price
- MAIA N/A
- BGM N/A
- AVG Volume (30 Days)
- MAIA 163.9K
- BGM 18.6K
- Earning Date
- MAIA 11-12-2024
- BGM 08-14-2024
- Dividend Yield
- MAIA N/A
- BGM N/A
- EPS Growth
- MAIA N/A
- BGM N/A
- EPS
- MAIA N/A
- BGM N/A
- Revenue
- MAIA N/A
- BGM $29,870,461.00
- Revenue This Year
- MAIA N/A
- BGM N/A
- Revenue Next Year
- MAIA N/A
- BGM N/A
- P/E Ratio
- MAIA N/A
- BGM N/A
- Revenue Growth
- MAIA N/A
- BGM N/A
- 52 Week Low
- MAIA $0.82
- BGM $1.78
- 52 Week High
- MAIA $5.99
- BGM $8.96
- Technical
- Relative Strength Index (RSI)
- MAIA 33.62
- BGM 37.44
- Support Level
- MAIA $2.42
- BGM $6.51
- Resistance Level
- MAIA $3.48
- BGM $7.82
- Average True Range (ATR)
- MAIA 0.29
- BGM 0.44
- MACD
- MAIA -0.06
- BGM -0.13
- Stochastic Oscillator
- MAIA 1.46
- BGM 22.42
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
About BGM QILIAN INTERNATIONAL HLDG GROUP LTD
BGM Group Ltd formerly, Qilian International Holding Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium.